Sommaire

• • ·Table of Contents

    Page :A3

    
• • ·Editorial Board

    Page :A7

    
• • ·Information for Readers

    Page :A8

    
• • ·Correction

    Page :1045

    

• Results of Expert Meetings

  • ·Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group

    Page :881

    Sunil V. Rao, John Eikelboom, Ph. Gabriel Steg, A. Michael Lincoff, William S. Weintraub, Jean-Pierre Bassand, A. Koneti Rao, C. Michael Gibson, John L. Petersen, Roxana Mehran, Steven V. Manoukian, Richard Charnigo, Kerry L. Lee, Mauro Moscucci, Robert A. Harrington, on behalf of the Academic Bleeding Consensus Multidisciplinary Working Group m

    Résumé Résumé Plan Plan

• Curriculum in Cardiology

  • ·Contemporary insights into the functional anatomy of the mitral valve

    Page :887-895

    Jeffrey J. Silbiger, Raveen Bazaz

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

    Page :896

    Gregory G. Schwartz, Anders G. Olsson, Christie M. Ballantyne, Phillip J. Barter, Ingar M. Holme, David Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Prediman K. Shah, Jean-Claude Tardif, Bernard R. Chaitman, Regina Duttlinger-Maddux, John Mathieson, on behalf of the dal-OUTCOMES Committees and Investigators

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

    Page :902

    Edoardo Camenzind, William Wijns, Laura Mauri, Eric Boersma, Keyur Parikh, Volkhard Kurowski, Runlin Gao, Christoph Bode, John P. Greenwood, Anthony Gershlick, William O'Neill, Patrick W. Serruys, Brenda Jorissen, P. Gabriel Steg, for the PROTECT Steering Committee and Investigators o

    Résumé Résumé Plan Plan  
  • ·The Balloon pump-assisted Coronary Intervention Study (BCIS-1): Rationale and design

    Page :910

    Divaka Perera, Rodney Stables, Jean Booth, Martyn Thomas, Simon Redwood, on behalf of the BCIS-1 Investigators

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience

    Page :917-924

    Behnam Banihashemi, Shaun G. Goodman, Raymond T. Yan, Robert C. Welsh, Shamir R. Mehta, Gilles Montalescot, Jan M. Kornder, Graham C. Wong, Gabor Gyenes, Ph. Gabriel Steg, Andrew T. Yan, for Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators

    Résumé Résumé Plan Plan  
  • ·Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of “resistance”

    Page :925-932

    Victor Serebruany, Ganesh Cherala, Craig Williams, Serge Surigin, Christopher Booze, Wiktor Kuliczkowski, Dan Atar

    Résumé Résumé Plan Plan  
  • ·Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease

    Page :933-940

    Matthew A. Cavender, Karen P. Alexander, Samuel Broderick, Linda K. Shaw, Charles B. McCants, Judith Kempf, E. Magnus Ohman

    Résumé Résumé Plan Plan  
  • ·Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: Results of a double-blind, placebo-controlled, randomized trial

    Page :941-947

    Yi-Da Tang, Faisal Hasan, Frank J. Giordano, Stephen Pfau, Henry M. Rinder, Stuart D. Katz

    Résumé Résumé Plan Plan  
  • ·Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: The Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHAT-LLT)

    Page :948-955

    Karen L. Margolis, Kay Dunn, Lara M. Simpson, Charles E. Ford, Jeff D. Williamson, David J. Gordon, Paula T. Einhorn, Jeffrey L. Probstfield, For the ALLHAT Collaborative Research Group

    Résumé Résumé Plan Plan  
  • ·Cardiac resynchronization therapy utilization for heart failure: Findings from IMPROVE HF

    Page :956-964

    Anne B. Curtis, Clyde W. Yancy, Nancy M. Albert, Wendy Gattis Stough, Mihai Gheorghiade, J. Thomas Heywood, Mark L. McBride, Mandeep R. Mehra, Christopher M. OConnor, Dwight Reynolds, Mary Norine Walsh, Gregg C. Fonarow

    Résumé Résumé Plan Plan  
  • ·Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure

    Page :965-971

    Kirkwood F. Adams, Ileana L. Piña, Jalal K. Ghali, Lynne E. Wagoner, Stephanie H. Dunlap, Todd A. Schwartz, Wendy Gattis Stough, Mandeep R. Mehra, Gary Michael Felker, Jun R. Chiong, James Herbert Patterson, John Kim, Javed Butler, Ron M. Oren

    Résumé Résumé Plan Plan  
  • ·The impact of kidney transplantation on heart failure risk varies with candidate body mass index

    Page :972-982

    Krista L. Lentine, Huiling Xiao, Daniel C. Brennan, Mark A. Schnitzler, Todd C. Villines, Kevin C. Abbott, David Axelrod, Jon J. Snyder, Paul J. Hauptman

    Résumé Résumé Plan Plan  
  • ·Prognostic importance of a restrictive transmitral filling pattern in patients with symptomatic congestive heart failure and atrial fibrillation

    Page :983-988

    Jakob Raunsø, Jacob Eifer Møller, Jesper Kjaergaard, Dilek Akkan, Christian Hassager, Christian Torp-Pedersen, Lars Køber, on behalf of the EchoCardiography and Heart Outcome Study (ECHOS) investigators

    Résumé Résumé Plan Plan  
  • ·Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparison

    Page :989-997

    Belen Cid-Alvarez, Francisco Gude, Carmen Cadarso-Suarez, Eva Gonzalez-Babarro, Maria Xose Rodriguez-Alvarez, Jose Maria Garcia-Acuna, Jose Ramon Gonzalez-Juanatey

    Résumé Résumé Plan Plan  
  • ·Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial

    Page :998

    Jeffrey S. Berger, Matthew T. Roe, C. Michael Gibson, Rakhi Kilaru, Cynthia L. Green, Laura Melton, James D. Blankenship, D. Christopher Metzger, Christopher B. Granger, Daniel D. Gretler, Cindy L. Grines, Kurt Huber, Uwe Zeymer, Pawel Buszman, Robert A. Harrington, Paul W. Armstrong

    Résumé Résumé Plan Plan  
  • ·Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial

    Page :1005-1010

    James B. Hermiller, Todd Fergus, Wesley Pierson, Xiaolu Su, Poornima Sood, Krishnankutty Sudhir, Gregg W. Stone

    Résumé Résumé Plan Plan
  • ·High incidence of TIMI flow 0 to I in patients with ST-elevation myocardial infarction without electrocardiographic lytic criteria

    Page :1011-1017

    Jaume Figueras, Ignacio Ferreira-González, Marcelo Rizzo, Oscar Alcalde, José A. Barrabés, Enric Domingo, Rosa M. Lidón, Josefa Cortadellas

    Résumé Résumé Plan Plan  
  • ·Impact of computerized dosing on eptifibatide-associated bleeding and mortality

    Page :1018-1023

    David R. Putney, Neal S. Kleiman, Robert E. Fromm, John M. Buergler

    Résumé Résumé Plan Plan  
  • ·The clinical significance of hematocrit values before and after percutaneous coronary intervention

    Page :1024-1030

    Gabriel Maluenda, Gilles Lemesle, Sara D. Collins, Itsik Ben-Dor, Asmir I. Syed, Rebecca Torguson, Kimberly Kaneshige, Zhenyi Xue, Rajbabu Pakala, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman

    Résumé Résumé Plan Plan  
  • ·Aerobic interval training versus continuous moderate exercise after coronary artery bypass surgery: A randomized study of cardiovascular effects and quality of life

    Page :1031-1037

    Trine T. Moholdt, Brage H. Amundsen, Lene Annette Rustad, Alexander Wahba, Kjersti T. Løvø, Lisbeth R. Gullikstad, Anja Bye, Eirik Skogvoll, Ulrik Wisløff, Stig A. Slørdahl

    Résumé Résumé Plan Plan  
  • ·Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

    Page :1038-1045

    Telly A. Meadows, Deepak L. Bhatt, Alan T. Hirsch, Mark A. Creager, Robert M. Califf, E. Magnus Ohman, Christopher P. Cannon, Kim A. Eagle, Mark J. Alberts, Shinya Goto, Sidney C. Smith, Peter W.F. Wilson, Karol E. Watson, P. Gabriel Steg, on behalf of the REACH Registry Investigators

    Résumé Résumé Plan Plan